Tegal Corp., which since 1972 has manufactured machines that make computer chips, is moving into the health I.T. market by acquiring oncology software vendor CollabRx Inc. for just over $930,000.

CollabRx sells oncology decision support software for physicians and their patients to assess tests, therapies and clinical trials for consideration. It has software for researchers to categorize molecular subtypes based on the genetic profile of a tumor, and link subtypes to relevant treatments. And it offers educational materials to aid patients in their treatment decision making.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access